Treatment in Türkiye, coordinated end to end
Patients choose this programme for what it contains: locally manufactured CAR-T products, accredited treatment centres, and coordination that does not end at discharge.
Regulatory trust
A healthcare system backed by international regulatory assessment
In international healthcare, a country's regulatory infrastructure is as important as its hospitals and physicians. The quality, safety and oversight of medicines and medical products are fundamental to patient safety.
TÜSEB
Türkiye Health Institutes Presidency
TİTCK
Turkish Medicines and Medical Devices Agency
Türkiye
Republic of Türkiye
T.C. Sağlık Bakanlığı
Ministry of Health
Health Tourism Authorization Certificate
Health Tourism Authorization Certificate
TİTCK — National Regulatory Authority
The Turkish Medicines and Medical Devices Agency (TİTCK) is Türkiye's national regulatory authority for medicines and health products. Its mandate covers product evaluation, licensing, quality control, market surveillance and pharmacovigilance — ensuring that every medical product used in treatment meets national and international standards.
WHO Maturity Level 3
The World Health Organisation assessed Türkiye's national medicines and vaccines regulatory system as Maturity Level 3 (ML3) — meaning a stable, well-functioning and integrated regulatory system. This assessment covers licensing, testing, market surveillance, pharmacovigilance and regulatory oversight.
EU-GMP Manufacturing Standards
CAR-T products in this programme are manufactured in an EU-GMP compliant facility in Ankara. EU-GMP (Good Manufacturing Practice) standards ensure that products are consistently produced and controlled according to quality standards — the same framework used across the European Economic Area.
ML3 indicates a stable, well-functioning and integrated regulatory system. It does not equate to WHO Listed Authority (WLA) status, which requires additional performance assessment. This distinction is important for accurate and transparent communication.
Local GMP manufacturing
An EU-GMP compliant CAR-T production centre in Ankara, established with TÜSEB support. Licensed CD19/CD22 dual-target and BCMA products manufactured to European quality standards, with an active clinical study running in three centres.
Health tourism authorisation
Registered with the Ministry of Health and listed on HealthTürkiye, with the International Health Tourism Authorisation Certificate. You can verify it yourself.
One coordinator, your language
A single point of contact from first message to follow-up: travel, accommodation, transfers, interpreter support and treatment scheduling — in your own language.
Materially lower cost
Programme costs are materially lower than comparable US and European programmes — with package terms discussed directly with you or your institution.
Follow-up that continues at home
Through a licensed home-care network covering 81 provinces with 300+ nurses and 95+ physicians, monitoring continues in your own country after you return.
Our own laboratories
Omega Genetics, the genetic diseases evaluation centre of our ecosystem, supports the programme with laboratory testing before and during treatment.
About Omega Genetics →Patient safety
Three layers of trust for advanced therapies
For advanced therapies like CAR-T, the treatment journey extends far beyond the hospital. Three interconnected layers of trust ensure patient safety at every step.
Strong healthcare system
The country must have adequate hospital capacity, intensive care, laboratory, imaging and specialist resources — backed by a regulatory system assessed to international standards.
Strong clinical centre
The treating centre must have an experienced, multidisciplinary team with specific expertise in the disease area and treatment modality — supported by structured protocols and quality systems.
Strong regulatory ecosystem
An effective national regulatory system must evaluate the quality, safety and efficacy of medicines and health products, and monitor their safety throughout their lifecycle — from manufacturing to post-market surveillance.
Regional reach
A healthcare bridge between regions
Türkiye's position at the crossroads of Europe, the Middle East, Central Asia and Africa — combined with its regulatory infrastructure — makes it a natural healthcare hub for diverse patient populations.
Africa
Healthcare infrastructure and regulatory systems vary significantly across African countries. For patients seeking advanced treatment abroad, Türkiye offers internationally assessed regulatory standards, experienced international patient services and direct flight connections from major African cities.
Middle East & North Africa
Türkiye's proximity to the MENA region, extensive flight network and experience with international patients create strong foundations. The WHO ML3 assessment of the national regulatory system adds an additional layer of confidence for patients from the region.
Turkic Republics & Central Asia
Historical, cultural and linguistic ties between Türkiye and the Turkic Republics facilitate the patient journey. Beyond cultural proximity, Türkiye offers advanced medical technology, strong clinical infrastructure and internationally assessed regulatory standards — a combination that matters especially for complex treatments.
Treatment centres
Treatment is delivered in accredited centres selected for the programme, including:
Memorial Hospital →
Istanbul, Ankara, Antalya
Anadolu Medical Center →
Gebze — Kocaeli
Başkent University Adana Hospital →
Adana
LÖSANTE Children's Hospital →
Ankara
Ankara Etlik Şehir Hastanesi →
Ankara
Hacettepe University Hospital →
Ankara
Gazi University Hospital →
Ankara
The centre for a specific patient is confirmed during the eligibility review, together with the treating team.
Health Tourism Authorisation Certificate
2026006015610080000497154 · 2026-06-05